Home Data Calendar Blog

TMDX

Tables

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Common Stock Value 634.46627.75674.16666.28660.06515.76513.20510.49508.46505.93503.91502.22501.49500.56424.79424.13NANA0.000.00NANANA
Weighted Average Number Of Diluted Shares Outstanding 32.6132.5532.26NA30.2327.9827.95NA27.7027.6227.37NA27.1623.3321.22NANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 32.6132.5532.26NA30.2327.9827.95NA27.7027.6227.37NA27.1623.3321.22NANANANANANANANA
Earnings Per Share Basic -0.78-0.03-0.08-0.20-0.25-0.41-0.38-0.46-0.47-0.39-0.29-0.22-0.19-0.36-0.42NANANANANANANANA
Earnings Per Share Diluted -0.78-0.03-0.08-0.20-0.25-0.41-0.38-0.46-0.47-0.39-0.29-0.22-0.19-0.36-0.42NANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Revenue From Contract With Customer Excluding Assessed Tax 66.4352.4741.5532.7624.3020.5215.889.675.418.677.647.637.973.928.246.067.886.215.293.544.753.262.76
Revenues 66.4352.4741.5531.3825.6820.5215.889.675.378.177.057.637.093.397.536.067.215.674.683.544.042.922.52
Cost Of Revenue 25.7715.7212.7910.677.576.173.782.681.602.582.242.802.051.482.672.322.992.332.10NA1.911.741.59
Gross Profit 40.6636.7428.7720.7018.1114.3512.106.993.775.594.814.835.041.914.863.744.223.332.571.502.131.180.92
Operating Expenses 69.0037.6530.8627.4823.6624.0921.4718.3115.5015.4611.3210.729.659.7712.8812.4411.4611.048.54NA6.076.335.71
Research And Development Expense 11.138.295.875.766.816.717.536.315.166.294.534.554.163.906.226.264.944.793.88NA3.273.433.46
Selling General And Administrative Expense 30.6529.3624.9821.7316.8517.3813.9412.0010.349.166.796.185.495.876.656.176.526.254.65NA2.802.902.24
Operating Income Loss -28.34-0.91-2.09-6.78-5.54-9.74-9.37-11.33-11.72-9.87-6.51-5.90-4.61-7.86-8.02-8.69-7.24-7.71-5.96-6.36-3.94-5.16-4.78
Interest Expense 3.592.501.091.010.790.970.960.980.980.960.950.970.971.001.041.061.081.111.09NA1.080.310.26
Gains Losses On Extinguishment Of Debt NANANA0.00NANANANANANANANANANANANANANANANANANANA
Allocated Share Based Compensation Expense 5.194.963.922.992.702.322.311.991.971.811.110.700.700.630.390.280.290.220.06NA0.030.030.03
Profit Loss -25.42-1.00-2.64-6.72-7.43-11.52-10.56-12.67-12.96-10.67-7.92-6.31-5.09-8.50-8.85-9.13-8.28-9.20-6.8939.92NA-6.12-4.90
Other Comprehensive Income Loss Net Of Tax -0.04-0.000.010.020.06-0.02-0.10-0.060.00-0.040.01-0.08-0.05-0.190.23-0.020.080.010.03NA0.010.00-0.00
Net Income Loss -25.42-1.00-2.64-6.72-7.43-11.52-10.56-12.67-12.96-10.67-7.92-6.31-5.09-8.50-8.85-9.18-8.28-9.20-6.89-7.63-5.11-6.12-4.90
Comprehensive Income Net Of Tax -25.46-1.00-2.63-6.70-7.37-11.54-10.66-12.72-12.96-10.71-7.91-6.39-5.14-8.69-8.62-9.20-8.20-9.19-6.86NA-5.09-6.11-4.90

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Assets 689.23690.36287.09277.15274.87117.28124.01134.89131.15140.51145.78152.03159.32163.1496.92105.30112.62121.0138.7642.16NANANA
Liabilities 562.77545.1494.4689.7787.0266.3764.1067.0452.6051.5348.1148.1349.7749.3850.2450.6549.1549.8551.2847.88NANANA
Liabilities And Stockholders Equity 689.23690.36287.09277.15274.87117.28124.01134.89131.15140.51145.78152.03159.32163.1496.92105.30112.62121.0138.7642.16NANANA
Stockholders Equity 126.46145.21192.62187.38187.8650.9259.9167.8578.5588.9897.67103.89109.55113.7646.6854.6563.4771.16NA-192.24-184.70-179.66-173.59

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Assets Current 536.72662.65261.73252.29250.5995.11105.80118.70125.58135.05140.54146.77154.13158.2391.70100.00107.37116.1330.0634.79NANANA
Cash 427.11582.21195.38201.18NANANANANANANANANANANANANANANANANANANA
Cash And Cash Equivalents At Carrying Value 427.11582.21195.38201.18204.4630.3917.9025.5822.5025.3126.7324.5821.4051.1524.7420.0920.4147.2412.2120.24NANANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 427.61582.96196.12201.68204.9630.8918.4026.0823.0025.8127.2325.0821.9051.6525.2420.5920.9147.7412.71NA29.3934.9410.30
Marketable Securities Current NANANANANA27.7054.1066.8780.3686.9491.39101.06111.3288.2247.8260.60NANANANANANANA
Accounts Receivable Net Current 60.6547.5238.6227.6122.0412.9811.725.934.156.277.396.866.144.436.136.566.467.115.153.44NANANA
Inventory Net 39.3730.5523.9620.6118.5717.4716.7114.8614.8713.0111.8211.9312.9812.5511.3611.2210.5411.2211.299.28NANANA
Prepaid Expense And Other Assets Current 9.602.383.772.905.516.585.365.463.703.523.212.332.291.871.661.542.091.571.401.84NANANA
Available For Sale Securities Debt Securities NANANANANA27.7054.1066.8780.3686.9491.39101.06111.3288.2247.8260.6067.8648.99NANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Property Plant And Equipment Gross 148.66NANA32.35NANANA19.58NANANA12.78NANANA11.14NANANA8.61NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 17.66NANA13.13NANANA9.73NANANA8.03NANANA6.35NANANA5.14NANANA
Property Plant And Equipment Net 131.0019.9619.1619.2218.4716.1812.049.845.064.954.734.754.694.404.714.794.754.383.753.47NANANA
Goodwill 11.67NANANANANANANANANANANANANANANANANANANANANANA
Intangible Assets Net Excluding Goodwill 2.40NANANANANANANANANANANANANANANANANANANANANANA
Finite Lived Intangible Assets Net 2.40NANANANANANANANANANANANANANANANANANANANANANA
Other Assets Noncurrent 0.060.060.51NANANANANA0.010.010.010.010.010.010.010.010.010.010.010.01NANANA
Available For Sale Debt Securities Amortized Cost Basis NANANANANA27.8054.2166.9180.3686.9391.37101.05111.2788.1147.5560.5467.8148.97NANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Liabilities Current 49.1032.0228.6423.6620.6922.7420.2623.2415.9215.0811.7611.8813.6213.8215.0416.1114.6415.3816.2012.55NANANA
Accounts Payable Current 12.847.034.333.343.085.712.936.652.682.391.291.210.783.724.867.254.776.665.504.72NANANA
Other Accrued Liabilities Current 5.334.492.663.405.754.964.534.622.981.551.641.521.951.721.660.931.581.571.380.49NANANA
Contract With Customer Liability Current 2.630.240.240.240.230.240.250.250.320.470.430.261.351.020.160.170.160.170.360.31NANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Long Term Debt Noncurrent NANA58.8058.7058.5435.4835.3335.2035.0634.9234.7934.6634.5234.4034.2734.1534.0233.9033.7833.67NANANA
Operating Lease Liability Noncurrent 8.238.467.037.427.798.158.518.60NANANANANANANANANANANANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Stockholders Equity 126.46145.21192.62187.38187.8650.9259.9167.8578.5588.9897.67103.89109.55113.7646.6854.6563.4771.16NA-192.24-184.70-179.66-173.59
Common Stock Value 634.46627.75674.16666.28660.06515.76513.20510.49508.46505.93503.91502.22501.49500.56424.79424.13NANA0.000.00NANANA
Retained Earnings Accumulated Deficit -507.74-482.31-481.31-478.68-471.96-464.53-453.01-442.45-429.78-416.82-406.15-398.23-391.92-386.83-378.33-369.48-360.31-352.03-342.83-335.94NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -0.26-0.22-0.22-0.23-0.25-0.31-0.28-0.19-0.13-0.13-0.09-0.10-0.020.040.23-0.000.02-0.06-0.07-0.10NANANA
Stock Issued During Period Value New Issues NANANANA139.85NANANANANANANANA75.04NANANA91.40NANANANANA

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities -6.87-5.80-8.66-4.04-14.28-9.09-18.41-6.65-9.35-5.54-7.33-7.14-6.41-8.54-8.18-7.26-5.60-12.16-7.27NANA-7.47-6.33
Net Cash Provided By Used In Investing Activities -149.83-1.38-0.93-2.7624.7522.0210.519.996.203.809.279.88-23.47-40.7212.717.36-18.77-49.09-0.00NANA6.974.96
Net Cash Provided By Used In Financing Activities 1.52394.013.963.06164.220.240.410.040.550.210.580.03-0.1875.540.15-0.25-2.4396.09-0.70NANA25.26-0.88

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities -6.87-5.80-8.66-4.04-14.28-9.09-18.41-6.65-9.35-5.54-7.33-7.14-6.41-8.54-8.18-7.26-5.60-12.16-7.27NANA-7.47-6.33
Net Income Loss -25.42-1.00-2.64-6.72-7.43-11.52-10.56-12.67-12.96-10.67-7.92-6.31-5.09-8.50-8.85-9.18-8.28-9.20-6.89-7.63-5.11-6.12-4.90
Profit Loss -25.42-1.00-2.64-6.72-7.43-11.52-10.56-12.67-12.96-10.67-7.92-6.31-5.09-8.50-8.85-9.13-8.28-9.20-6.8939.92NA-6.12-4.90
Depreciation Depletion And Amortization 1.891.391.291.280.890.800.510.470.460.450.450.430.400.370.370.360.330.290.24NANA0.170.17
Increase Decrease In Accounts Receivable 11.138.9010.965.399.161.335.801.81-2.09-1.140.580.691.66-1.71-0.420.07-0.581.941.75NANA0.801.02
Increase Decrease In Inventories 10.057.353.621.931.941.232.930.932.071.510.38-0.660.991.170.240.880.010.762.47NANA0.851.18
Increase Decrease In Accounts Payable 2.872.651.030.26-1.922.40-4.013.860.291.02-0.080.61-2.59-1.42-2.412.39-0.390.680.76NANA0.07-0.84
Share Based Compensation 5.194.963.922.992.702.322.311.991.971.811.110.700.700.630.390.280.290.220.06NANA0.030.03

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Net Cash Provided By Used In Investing Activities -149.83-1.38-0.93-2.7624.7522.0210.519.996.203.809.279.88-23.47-40.7212.717.36-18.77-49.09-0.00NANA6.974.96
Payments To Acquire Property Plant And Equipment 107.721.380.932.762.934.261.953.180.070.250.020.000.060.120.28-0.020.030.150.00NANA0.000.04

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Net Cash Provided By Used In Financing Activities 1.52394.013.963.06164.220.240.410.040.550.210.580.03-0.1875.540.15-0.25-2.4396.09-0.70NANA25.26-0.88

    2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31
Revenues 66.4352.4741.5531.3825.6820.5215.889.675.378.177.057.637.093.397.536.067.215.674.683.544.042.922.52
Ocs Heart Product NANANANA11.548.065.716.052.854.604.182.425.432.224.133.143.742.641.92NA1.641.591.63
Ocs Liver Product NANANANA12.549.627.871.470.000.000.442.121.000.741.390.001.350.801.34NA0.910.380.18
Ocs Lung Product NANANANA1.602.842.302.142.523.572.433.090.660.432.012.922.112.221.41NA1.490.950.71
Unrelated To Ocs Transplant 2.40NANANANANANANANANANANANANANANANANANANANANANA
Product 47.7442.4633.9925.0721.3017.9214.94NANANANANANANANANANANANANANANANA
Service 18.6910.007.566.304.382.600.94NANANANANANANANANANANANANANANANA
Heart Product,US NA13.4612.96NANA5.883.74NANANANANANANANANANANANANANANANA
Heart Product, Other Countries NA3.113.80NANA2.191.97NANANANANANANANANANANANANANANANA
Liver Product,US NA32.6723.11NANA9.627.87NANANANANANANANANANANANANANANANA
Liver Product, Other Countries NA0.01NANANANANANANANANANANANANANANANANANANANANA
Lung Product,US NA2.821.43NANA2.641.95NANANANANANANANANANANANANANANANA
Lung Product, Other Countries NA0.400.25NANA0.190.35NANANANANANANANANANANANANANANANA
Heart Product,US, Ocs Transplant Revenue 15.07NANANA9.30NANANANANANANANANANANANANANANANANANA
Heart Product, Other Countries, Ocs Transplant Revenue 3.89NANANA2.24NANANANANANANANANANANANANANANANANANA
Liver Product,US, Ocs Transplant Revenue 41.21NANANA12.54NANANANANANANANANANANANANANANANANANA
Liver Product, Other Countries, Ocs Transplant Revenue 0.10NANANANANANANANANANANANANANANANANANANANANANA
Lung Product,US, Ocs Transplant Revenue 3.41NANANA1.44NANANANANANANANANANANANANANANANANANA
Lung Product, Other Countries, Ocs Transplant Revenue 0.31NANANA0.16NANANANANANANANANANANANANANANANANANA
Ocs Transplant Revenue 63.99NANANA25.68NANANANANANANANANANANANANANANANANANA
US NA48.9537.5029.0523.2918.1413.567.233.115.765.765.675.922.445.214.664.344.302.95NA2.241.330.82
Non Us And Uk NANANANANA2.382.324.361.901.310.824.100.490.601.21NA2.090.961.15NANANANA
Other Countries NA3.524.052.322.402.382.322.432.26NANANANA0.601.211.201.650.141.15NA0.440.080.00
US, Ocs Transplant Revenue 59.69NANANA23.29NANANANANANANANANANANANANANANANANANA
Other Countries, Ocs Transplant Revenue 4.30NANANA2.40NANANANANANANANANANANANANANANANANANA
Revenue From Contract With Customer Excluding Assessed Tax 66.4352.4741.5532.7624.3020.5215.889.675.418.677.647.637.973.928.246.067.886.215.293.544.753.262.76

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Interest Expense
Balance Sheet
Intangible Assets Net Excluding Goodwill
Assets
Intangible Assets Net Excluding Goodwill
Current Assets
Prepaid Expense And Other Assets Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Operating Lease Liability Current
Noncurrent Liabilities
Operating Lease Liability Noncurrent
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInFinancingActivities
Proceeds From Issuance Of Long Term Debt
Shares
Weighted Average Number Of Diluted Shares Outstanding
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Due Next Twelve Months
FiniteLivedIntangibleAssets
Finite Lived Intangible Assets Accumulated Amortization
InventoryNet
Inventory Work In Process Net Of Reserves

Line plots across dimensions of each concept


Cost Ratio
us-gaap:ProductOrService
(None,)
Cost  Ratious-gaap: Product Or Service
TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments
(None, 'tmdx:OcsTransplantRevenue')
Revenuesus-gaap: Statement Geographical, us-gaap: Statement Business Segments
us-gaap:CostOfRevenue
us-gaap:ProductOrService
(None,)
Cost Of Revenueus-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FairValueByFairValueHierarchyLevel, us-gaap:FinancialInstrument
('us-gaap:FairValueInputsLevel2', None)
Available For Sale Securities Debt Securitiesus-gaap: Fair Value By Fair Value Hierarchy Level, us-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:Revenues
us-gaap:StatementGeographical
(None,)
Revenuesus-gaap: Statement Geographical
us-gaap:Revenues
us-gaap:ProductOrService
(None,)
Revenuesus-gaap: Product Or Service
us-gaap:Revenues
us-gaap:StatementGeographical, us-gaap:StatementBusinessSegments
(None, 'tmdx:OcsTransplantRevenue')
Revenuesus-gaap: Statement Geographical, us-gaap: Statement Business Segments